Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

WSE/MRC stock hub

WSE/MRC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

WSE/MRCis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
551.5M
Warsaw Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
WSE/MRC
In the news

Latest news · WSE/MRC

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E5.6
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-2.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All WSE/MRC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
196
Groups with data
11
Currency
PLN
Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Poland
Country code
PL
Employees
950
Employees Change
-11%
Employees Change Percent
-1.14
Enterprise value
PLN 368.5M
Exchange
Warsaw Stock Exchange
Financial currency
PLN
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
PLMRCTR00015
Last refreshed
2026-05-10
Market cap
PLN 551.5M
Price
PLN 59.5
Price currency
PLN
Rev Per Employee
616,386.32x
Sector
Healthcare
Sic
3842
Symbol
wse/MRC
Website
https://en.mercatormedical.eu

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
17.73%
EV Earnings
3.77x
EV/EBITDA
69.55x
EV/FCF
-3.69x
EV/Sales
0.63x
FCF yield
-18.12%
P/B ratio
0.62x
P/E ratio
5.64x
P/S ratio
0.94x
PE Ratio10 Y
13.68x
PE Ratio5 Y
10.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
-2.94%
EBITDA Margin
0.91%
Gross margin
27.6%
Gross Profit
PLN 161.6M
Gross Profit Growth
12.64%
Gross Profit Growth Q
14.63%
Gross Profit Growth3 Y
6.75%
Gross Profit Growth5 Y
-27.01%
Net Income
PLN 97.8M
Net Income Growth Years
0%
Net Income Growth3 Y
70.79%
Net Income Growth5 Y
-30.02%
Pretax Margin
12.97%
Profit Margin
16.69%
Profit Per Employee
PLN 102,901
Profitable Years
2
Roa5y
18.13
ROCE
-1.86
Roe5y
37
ROIC
-2.41
Roic5y
58.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
14.74%
Cagr1y
34.19%
Cagr3y
14.95%
Cagr5y
-24.15%
Div CAGR3
71%
Div CAGR5
80.63%
EPS Growth Years
0
EPS Growth3 Y
73.86
EPS Growth5 Y
-28.1
Revenue Growth
14.77x
Revenue Growth Q
4.11x
Revenue Growth Years
2x
Revenue Growth3 Y
-5.98x
Revenue Growth5 Y
-14.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Assets
PLN 1B
Cash
PLN 203.5M
Current Assets
PLN 554.6M
Current Liabilities
PLN 79.8M
Debt
PLN 23.6M
Debt EBITDA
PLN 4.43
Debt Equity
PLN 0.03
Debt FCF
PLN -0.24
Equity
PLN 890.1M
Interest Coverage
-38.74
Liabilities
PLN 113.8M
Long Term Assets
PLN 449.2M
Long Term Liabilities
PLN 34M
Net Cash
PLN 179.9M
Net Cash By Market Cap
PLN 32.62
Net Debt EBITDA
PLN -33.82
Net Debt Equity
PLN -0.2
Tangible Book Value
PLN 864.3M
Tangible Book Value Per Share
PLN 93.25
WACC
3.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
6.95
Net Working Capital
PLN 275.3M
Quick ratio
3.73
Working Capital
PLN 474.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

4
MetricValue
Buyback Yield
1.96%
Dividend per share
PLN 1.61
Dividend Yield
2.71%
Last Dividend
PLN 2.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
295.31%
1Y total return
34.16%
200-day SMA
43.29
3Y total return
51.89%
50-day SMA
46.91
50-day SMA vs 200-day SMA
50over200
5Y total return
-74.89%
All Time High
770
All Time High Change
-92.27%
All Time High Date
2020-10-14
All Time Low
4.93
All Time Low Change
1,106.9%
All Time Low Date
2019-05-20
ATR
3.05
Beta
-0.03
Beta1y
0.43
Beta2y
0.51
Ch YTD
56.99
High
59.8
High52
62.7
High52 Date
2026-04-07
High52ch
-5.1%
Low
56.1
Low52
37
Low52 Date
2025-12-23
Low52ch
60.81%
Ma50ch
26.84%
Price vs 200-day SMA
37.44%
RSI
68.59
RSI Monthly
60.06
RSI Weekly
80.42
Sharpe ratio
0.78x
Sortino ratio
1.69
Total Return
4.67%
Tr YTD
56.99
Tr1m
-2.62%
Tr1w
24.87%
Tr3m
45.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
PLN -17.2M
Operating margin
-2.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
3,416,534%
Net Borrowing
-1,941,000
Shares Institutions
1.3%
Shares Out
9,268,813
Shares Qo Q
12.69%
Shares Yo Y
-1.96%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
PLN -99.9M
Average Volume
20,768.35x
Bv Per Share
96.36
CAPEX
PLN -40.3M
Ch10y
268.6
Ch1m
-2.62
Ch1w
24.87
Ch1y
34.16
Ch3m
45.83
Ch3y
43.72
Ch5y
-76.24
Ch6m
49.31
Change
2.94%
Change From Open
2.23
Close
57.8
Days Gap
0.69
Depreciation Amortization
22,521,000
Dollar Volume
3,597,310.5
Earnings Date
2026-04-30
EBIT
PLN -17.2M
EBITDA
PLN 5.3M
EPS
PLN 10.56
F Score
1
FCF
PLN -99.9M
FCF EV Yield
-27.11x
FCF Per Share
PLN -10.78
Financing CF
-29,742,000
Fiscal Year End
December
Founded
1,989
Graham Number
151.27819
Graham Upside
154.2
Income Tax
PLN -22M
Investing CF
50,328,000
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2025-09-30
Lynch Fair Value
PLN 52.78
Lynch Upside
-11.3
Ma150
42.6
Ma150ch
39.69%
Ma20
51.8
Ma20ch
14.86%
Net CF
-37,457,000
Next Earnings Date
2026-06-01
Open
58.2
Position In Range
91.89
Ppne
332,432,000
Price Date
2026-05-08
Price EBITDA
PLN 104
Ptbv Ratio
0.64
Relative Volume
2.76x
Revenue
585,567,000x
Tax By Revenue
-3.75x
Tr6m
49.31%
Volume
60,459
Z Score
4.82
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

WSE/MRC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.7%
$1.61 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+80.6%
Annualized growth of the per-share dividend
Total shareholder yield
+4.7%
Dividend yield + buyback yield combined
Performance

WSE/MRC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+34.2%
S&P 500 1Y: n/a
3Y total return
+51.9%
S&P 500 3Y: n/a
5Y total return
-74.9%
S&P 500 5Y: n/a
10Y total return
+295.3%
S&P 500 10Y: n/a
Ownership

Who owns WSE/MRC?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.3%
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.0%
Negative means the company is buying back shares.
Technical

WSE/MRC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
68.6
Neutral momentum band
Price vs 200-day MA
+37.4%
50/200-day relationship not available
Beta (5Y)
-0.03
Less volatile than the market
Sharpe ratio
0.78
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About WSE/MRC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/MRC stock rating?

wse/MRC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/MRC analysis?

The full report lives at /stocks/wse/MRC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/MRC?

The latest report frames wse/MRC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/MRC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

wse/MRC stock profile: metrics, valuation and analysis | 股票市场 AI 助手